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The uptake of 2-[ 1-r‘+C]deoxyglucose in vivo by brown adipose tissue was greater than that of brain or heart 
in control mice on a whole tissue basis. When mice were treated with noradrenaline the rate of uptake of 
2-[l-%]deoxyglucose by brown adipose tissue was increased 6-fold with the only other change occurring 
in heart where a Sfold increase was observed. After administration f insulin the uptake of 2-[ I-%]deoxy- 
glucose in vivo was increased in heart, brown adipose tissue, white adipose tissue and muscle. The amount 
of 2-[l-%]deoxyglucose taken up by brown adipose tissue compared to other tissues and the changes in 
this uptake after administration of noradrenaline or insulin suggest hat brown adipose tissue is capable 
of playing a quantitatively important role in glucose removal from the blood. 
Brown adipose tissue 2-Deoxyglucose 
1. INTRODUCTION 
Recent studies have determined that brown 
adipose tissue (BAT) is responsible for a signifi- 
cant amount of the heat production seen in non- 
shivering and diet-induced thermogenesis in mam- 
mals [l]. The lipogenic capacity of this tissue has 
also been widely investigated and it has been sug- 
gested that in animals fed a high carbohydrate diet, 
blood glucose is the major percursor for this 
lipogenesis [2-41. Although it is generally accepted 
that the fuel for thermogenesis in BAT isofatty 
acids, there is no direct evidence that this is always 
the case. It has been suggested that glucose may be 
used as a direct fuel for thermogenesis as well as a 
lipogenic precursor [5], but there are no reports of 
the extent of glucose uptake in vivo by BAT. The 
high rates of lipogenesis observed in BAT under 
certain conditions coupled with the high activities 
of the glycolytic enzymes hexokinase and 6-phos- 
phofructokinase indicate that despite its small size 
Insulin Noradrenaline Glucose uptake 
(l-2% of body weight), BAT could utilise a con- 
siderable amount of glucose and therefore be im- 
portant in removal of glucose from the blood [6,7]. 
The uptake of the glucose analogue 2-deoxyglu- 
case in vivo has been used as an index of relative 
glucose uptake in tissues of the rat [&lo]. 2-Deoxy- 
glucose is transported by the glucose transport 
system and becomes trapped in the tissue after 
phosphorylation by hexokinase. The accumulation 
of label thus reflects the overall process of 
transport and phosphorylation by a tissue [8]. 
Here, the uptake of 2-[1-i4C]deoxyglucose was 
measured in BAT and in the major glucose utilising 
tissues of adult mice to give some indication of the 
relative importance of BAT in whole body glucose 
utilisation. The effects of noradrenaline and in- 
sulin on 2-deoxyglucose uptake were also investi- 
gated, since noradrenaline stimulates thermogenic 
activity in BAT [l l] and BAT is known to be an 
insulin-sensitive tissue [ 12,131. 
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2. MATERIALS AND METHODS 
Male QS mice were obtained from the Bosch 
Animal House, University of Sydney. The mice 
were maintained at 22°C under a 12 h light/dark 
cycle and fed on a standard laboratory diet (Rat 
and Mouse Kubes; Allied Feeds, Rhodes, NSW). 
For experiments on deoxyglucose uptake mice 
were lightly anaesthetized with phenobarbitone (50 
mg/kg i.p.) and injected intravenously with 2- 
[l-14C]deoxyglucose (45 &i/ml Amersham, Eng- 
land) at a dose of 150 &i/kg. Where indicated 
noradrenaline (Leverophed, Winthrop Sydney, 
Australia; 260pg/kg) and insulin (Actrapid, NOVO, 
Copenhagen, 0.5 units/kg) were injected i.v. with 
2-[ 1 -‘4C]deoxyglucose (total volume 0.2 ml). 
Samples of blood (5 ~1) were taken from the tip of 
the tail at 1,2,5,10,20 and 30 min after injection of 
label. These samples were immediately deprotein- 
ised by addition of 0.05 ml of 6% HC104 and cen- 
trifuged in an Eppendorf microfuge (12 000 x g, 3 
min). The supernatant was used for the determina- 
tion of blood glucose [14] and blood radioactivity. 
After 30 min the mice were killed by cervical 
dislocation and the heart, liver, brain, interscapular 
BAT, white adipose tissue (epididymal) and skeletal 
muscle (quadriceps) removed and quickly frozen in 
liquid nitrogen. Samples of these tissues (100-400 
mg) were homogenised in 1.2 ml of 6% HC104 : 80 
mM triethanolamine HCl and centrifuged at 
12000 xg for 5 min in an Eppendorf microfuge. 
The supernatants were neutralised with KOH and 
0.5 ml applied to individual plastic columns of 
Dowex 2-formate (prepared from Dowex 2-chloride 
2 x 8-400 Sigma, St. Louis, MO) for separation of 
2-[l-14C]deoxyglucose from 2-[1-i4C]deoxyglucose 
6-phosphate [15]. Addition of 5 ml Hz0 eluted 
2-[l-14C]deoxyglucose and subsequent elution with 
5 ml of 1 M formic acid/O.3 M ammonium for- 
mate yielded 2-[l-14C]deoxyglucose 6-phosphate. 
Calculation of the recovery of label showed that 
95-100% of the radioactivity added to the column 
was present in the two fractions collected. The up- 
take of 2-[l-14C]deoxyglucose by tissues is ex- 
pressed as dpm/total tissue except for white 
adipose tissue and skeletal muscle where results are 
expressed as dpm/g wet wt. It was assumed that in- 
terscapular BAT accounted for 25% of the total 
BAT when calculating 2-[l-14C]deoxyglucose up- 
take in this tissue [16]. 
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The model used to calculate the rate constant 
(K) of net tissue uptake of 2-[l-14C]deoxyglucose is 
based upon the assumption that the rate of disap- 
pearance of label from the blood is the sum of all 
individual tissue rates of uptake [lo]. For a single 
injection of tracer where the plasma disappearance 
of label is treated as a single exponential function: 
K= CK, 
c,, (1 - e?q 
where K is the rate constant for net tissue uptake 
in a given tissue, C the concentration of label in the 
tissue (dpm/g), C,, the initial plasma concentra- 
tion of radioactivity and Kp the plasma disap- 
pearance rate constant. No correction was made 
for label in the extracellular space of tissues and it 
was presumed that all 2-[ l-‘4C]deoxyglucose 
6-phosphate was intracellular. 
3. RESULTS AND DISCUSSION 
The blood glucose level of control, noradrena- 
line-treated and insulin-treated animals over the 30 
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Fig.1. Blood glucose concentration of control, nor- 
adrenaline- and insulin-treated mice. For experimental 
details see section 2. Each group contained 8 animals 
and points represent the mean SE for blood samples 
taken at the times indicated. Control (o), noradrenaline- 
treated (+), insulin-treated (*). 
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Fig.2. Concentration of 2-[1-r4C]deoxyglucose in the 
blood of control, noradrenaline- and insulin-treated 
mice. Each line represents a linear regression through 
time points on a log-linear scale to enable calculation of 
plasma disappearance rates of radioactivity for the 3 
experimental groups. Control (o), noradrenaline-treated 
(*), insulin-treated (*). 
min of 2-[l-14C]deoxyglucose uptake is shown in 
fig. 1. For the mice injected with noradrenaline the 
blood glucose level is slightly higher than control 
mice, perhaps due to noradrenergic stimulation of 
liver glycogenolysis. However, for control and 
noradrenaline-treated animals the blood glucose 
level remains constant during the course of the ex- 
periment. In the insulin-treated mice the blood 
glucose level decreased after administration of in- 
sulin indicating increased glucose uptake by 
insulin-sensitive tissues. 
The rate of disappearance of labelled deoxyglu- 
case from the blood in the 3 experimental groups 
of mice is shown in fig.2. In all 3 situations the 
disappearance rate fits a single exponential func- 
tion enabling calculation of Kp and initial plasma 
radioactivity (C,,) for use in determination of the 
deoxyglucose uptake constant (K) for any tissue 
[8]. The correlation coefficients for the linear 
regressions of each line were: control, -0.997; 
noradrenaline, -0.991; and insulin, -0.998 and 
the initial plasma radioactivity for each group was 
588 840, 501 187 and 524 807 dpm/ml for control, 
noradrenaline- and insulin-treated mice, respec- 
tively. The same initial specific radioactivity is seen 
in all groups, so comparison between the tissues of 
different groups is possible. 
Using the above data and the mathematical 
model described in section 2, values for the rate 
constant of 2-[1-i4C]deoxyglucose uptake (K) were 
calculated (table 1). In control animals the K for 
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Fig.3. Relative tissue uptake of 2-[l-‘4C]deoxyglucose in 
vivo of control, noradrenaline- and insulin-treated mice. 
Experimental details are given in section 2. The hatched 
area is the amount of 2-[ I-r4C]deoxyglucose 6-phosphate. 
There was no significant difference between the weights 
of tissues from different groups. The average weights of 
the tissues were brain (Br), 0.407 + 0.007; heart (H) 
0.177 f 0.004, liver (L), 1.703 + 0.072, and BAT 0.324 
f 0.020. White adipose tissue (W) and muscle (M) 
results are expressed per g fresh wt. 
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Table 1 
Calculated rate constants for 2-[l-‘4C]deoxyglucose uptake in vivo in 
tissue of control, noradrenaline- and insulin-treated mice 
K 
Control Noradrenaline Insulin 
Brain 0.0136 + 0.0013 0.0108 * 0.0008 0.0146 & 0.0010 
Heart 0.0134 + 0.0015 0.0803 + 0X163~ 0.1125 + 0~)088~ 
Liver 0.0204 + 0.0012 0.0207 t 0.0012 0.0215 f 0.0014 
Brown 
Fat 0.0165 f 0.0012 0.0953 + 0.0128a 0.0623 + 0.0041” 
White 
Fat 0.0033 f 0.0002 0.0028 f 0.0003 0.0130 * 0.0019” 
Muscle 0.0040 + 0.0002 0.0035 + 0.0002 0.0178 * 0.0014” 
K values were calculated as described in section 2. The values are the 
mean SE for 8 separate measurements. Significant difference from 
control values was determined using Student’s t-test; ‘P<0.005 
BAT is similar to that of brain and heart and 
greater than white adipose and muscle. When mice 
were treated with noradrenaline the only signifi- 
cant changes in K value were in heart and BAT 
where a 6- and 5.7-fold increase respectively, were 
observed. Administration of noradrenaline in- 
creases the heart rate and the thermogenic activity 
of BAT and so the increased rate of deoxyglucose 
uptake observed is probably due to the increased 
energy demands of these 2 tissues. The stimulation 
of uptake in BAT is probably a direct effect of 
noradrenaline on the tissue but may also represent 
an increased blood flow to BAT in response to 
noradrenaline [ 171. 
In mice treated with insulin there was no signifi- 
cant change in K for brain, but heart, BAT, white 
adipose tissue and muscle all responded with 
significant increases in the rate of deoxyglucose 
uptake. The largest increase was in heart (8.4-fold) 
while in BAT, white adipose tissue and muscle, the 
increases were 3.8-, 3.9- and 4.5-fold, respectively. 
Although the K values in white adipose tissue, 
muscle and BAT increased by the same amount 
after insulin administration, the absolute rate of 
glucose uptake in BAT was 3-times higher than 
that of white adipose tissue and muscle, indicating 
the large capacity of BAT for glucose uptake. 
Values for K in liver are not included since in this 
tissue the deoxyglucose uptake model is not valid. 
Liver contains glucose-6-phosphatase which could 
dephosphorylate 2-[l-14C]deoxyglucose B-phos- 
phate and return it to the blood [8]. In liver, 
therefore, the amount of 2-[l-14C]deoxyglucose 
6-phosphate represents the equilibrium between 
the glucose phosphorylating and dephosphorylating 
activity of the tissue at the end of the experiment. 
The total amount of labelled deoxyglucose ac- 
cumulated in the tissues and the proportion of 
deoxyglucose in the phosphorylated form is shown 
in fig.3. In control animals the amount of deox- 
yglucose in BAT is greater than brain or heart in- 
dicating that in normal animals BAT takes up a 
considerable amount of glucose from the blood. 
When thermogenesis is stimulated by noradrenaline 
the deoxyglucose is increased 3.5fold in BAT and 
5-fold in heart. Under thermogenic conditions, 
therefore, a substantial amount of the circulating 
blood glucose would be taken up by BAT although 
liver, white adipose tissue and muscle, because of 
their large percentage of the body weight, would 
still be major tissues for glucose disposal. 
When mice were injected with insulin the amount 
of label in BAT, heart, white adipose tissue and 
muscle all increased. The major tissues for glucose 
uptake in insulin-treated animals would be muscle 
and white adipose tissue, but on a g wet wt basis 
BAT was second to heart in deoxyglucose uptake 
and accumulated 4-times as much label as muscle 
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and white adipose tissue (not shown). The uptake 
in brain remained the same as in control animals 
confirming the previous finding that brain is essen- 
tially insulin insensitive for glucose uptake [9]. The 
amount of label recovered from liver of insulin- 
treated mice is only half that of the control 
animals. This decrease is probably due to the 
decrease in the blood glucose level since the glucose 
(and therefore deoxyglucose) concentration in liver 
is in equilibrium with blood glucose [18]. 
The changes in the 2-[ l-‘4C]deoxyglucose uptake 
of BAT and the relative amount of label in BAT 
compared to other insulin-sensitive tissues show 
that BAT, despite its small proportion of body 
weight, plays a significant role in glucose utilisa- 
tion. In BAT, glucose metabolism leads to acetyl- 
CoA formation which will be oxidised or con- 
verted to lipid for storage and subsequent oxida- 
tion in BAT. Oxidation of substrates by BAT 
results in heat production and therefore loss of the 
energy equivalent of the substrate [11. If uptake of 
glucose or its subsequent oxidation was defective 
in BAT excess energy intake might be channelled 
to white adipose tissue, liver and muscle where 
glucogen and fat production (and deposition) 
would result rather than heat production. Defec- 
tive thermogenic mechanisms in BAT are well 
documented in genetically obese mice and rats 
[19-211 and changes in BAT have also been im- 
plicated to play a role in genetically diabetic mice 
[22]. The present results add evidence to the sug- 
gestion that defects in the metabolism of glucose 
by BAT may be important in the disorders of car- 
bohydrate metabolism which occur in diabetes and 
obesity [7]. 
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